Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

Published:2016-10 Issue:10056 Volume:388 Page:2153-2163
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

French Jacqueline A,Lawson John A,Yapici Zuhal,Ikeda Hiroko,Polster Tilman,Nabbout Rima,Curatolo Paolo,de Vries Petrus J,Dlugos Dennis J,Berkowitz Noah,Voi Maurizio,Peyrard Severine,Pelov Diana,Franz David N

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. The natural history of epilepsy in tuberous sclerosis complex;Chu-Shore;Epilepsia,2010

2. Neurological and neuropsychiatric aspects of tuberous sclerosis complex;Curatolo;Lancet Neurol,2015

3. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy;Curatolo;Pediatr Neurol,2015

4. Drug-resistant epilepsy;Kwan;N Engl J Med,2011

5. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies;Wong;Epilepsia,2010

Cited by 579 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NS-Pten knockout mice exhibit sex and hippocampal subregion-specific increases in microglia/macrophage density;Epilepsy Research;2024-10

2. Developmental and epileptic encephalopathies;Nature Reviews Disease Primers;2024-09-05

3. Genetic advances in neurodevelopmental disorders;Medical Review;2024-09-03

4. A dermatological assessment of pediatric patients with tuberous sclerosis complex (TSC);Anais Brasileiros de Dermatologia;2024-09

5. Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of Ireland;Journal of Rare Diseases;2024-08-19